Edwards Lifesciences (EW) EBITDA Margin (QoQ) (2009 - 2026)
Edwards Lifesciences (EW) EBITDA Margin (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn |
| 2 | Stryker | 127.77 Bn | 124.29 Bn | 4.50 Bn |
| 3 | Medtronic | 119.02 Bn | 109.80 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.39 Bn | 23.07 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.58 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.21 Bn | 18.80 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 51.00 |
| Mar 31, 2026 | 1,934.00 |
| Dec 31, 2025 | -1,015.00 |
| Sep 30, 2025 | -706.00 |
| Jun 30, 2025 | -111.00 |
| Mar 31, 2025 | 539.00 |
| Dec 31, 2024 | -333.00 |
| Sep 30, 2024 | -88.00 |
| Jun 30, 2024 | 52.00 |
| Mar 31, 2024 | -114.00 |
| Dec 31, 2023 | -204.00 |
| Sep 30, 2023 | 882.00 |
| Jun 30, 2023 | -1,120.00 |
| Mar 31, 2023 | -1,419.00 |
| Dec 31, 2022 | 1,548.00 |
| Sep 30, 2022 | -294.00 |
| Jun 30, 2022 | 73.00 |
| Mar 31, 2022 | 456.00 |
| Dec 31, 2021 | -163.00 |
| Sep 30, 2021 | -961.00 |